Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
D06006(Tacrolimus)
Innopharmax Inc. Taiwan flag Taiwan
Abstract ID:
Tacrolimus is an immunosuppressive agent. Protopy is available in the form of ointment for cutaneous use....
Contact Betty Tsai
Participants
You
Email me a copy of this message
MECHANISM OF ACTION
Tacrolimus binds to an intracellular protein, FKBP-12. A complex of tacrolimus-FKBP-12, calcium, calmodulin, and calcineurin is then formed and the phosphatase activity of calcineurin inhibited.
Tacrolimus, as an immuno-suppresant with a low aqueous solubility, has been widely used for the inhibition of graft rejection in organ transplant recipients. INNOPHARMAX OralPASŪ Tacrolimus gel Capsules are designed to improve the bioavailability of Tacrolimus via oral administration.
Type of Business Relationship Sought
License out/co-development
FEATURED
Last Updated Nov 2014
Technology Type THERAPEUTIC
Phase of Development
CORPORATION